Matavelli Luis C, Kadowitz Philip J, Navar L Gabriel, Majid Dewan S A
Dept. of Physiology, Tulane Univ. Health Sciences Center, 1430 Tulane Ave., SL 39, New Orleans, LA 70112, USA.
Am J Physiol Renal Physiol. 2009 Jan;296(1):F170-6. doi: 10.1152/ajprenal.90487.2008. Epub 2008 Nov 5.
Peroxynitrite (ONOO(-)) is formed endogenously by the reaction of nitric oxide (NO) and superoxide (O(2)(-)). To examine the hypothesis that OONO(-) cause renal vasodilation at low concentrations but cause vasoconstriction at higher concentrations, we examined renal responses to intra-arterial infusion of incremental doses of OONO(-) (10, 20, and 40 microg.kg(-1).min(-1); 45 min each) in anesthetized rats. Renal blood flow (RBF) and glomerular filtration rate (GFR) were determined by PAH and inulin clearance. In control rats (n = 6), low dose (10 microg.kg(-1).min(-1)) of OONO(-) increased RBF by 10 +/- 3% and GFR by 15 +/- 5%. The higher doses (20 and 40 microg.kg(-1).min(-1)) mostly reversed these responses which were -7 +/- 4 and -27 +/- 7% (P < 0.05) in RBF and -0.1 +/- 4.8 and -14 +/- 12% in GFR, respectively. There were no appreciable changes in urine flow (V) and sodium excretion (U(Na)V) during OONO(-) infusion. However, in rats pretreated with NO synthase (NOS) inhibitor, l-NAME (50 microg.kg(-1).min(-1); n = 5), these doses of ONOO(-) significantly reduced RBF (-26 +/- 7, -27 +/- 6, and -44 +/- 3%) and GFR (-21 +/- 6, -25 +/- 8, and -32 +/- 12%) with variable increases in V or U(Na)V. Long-term infusion of OONO(-) (10 microg.kg(-1).min(-1) for 75 min) in another set of control rats (n = 5) also showed similar vasodilator and hyperfiltration responses. These data indicate that ONOO(-) acts as an oxidant at high concentration but provides renoprotective function at low concentration that depends on intact NOS activity.
过氧亚硝酸盐(ONOO(-))由一氧化氮(NO)和超氧化物(O(2)(-))内源性反应生成。为检验低浓度的ONOO(-)可引起肾血管舒张而高浓度时则引起血管收缩这一假说,我们在麻醉大鼠中研究了肾对动脉内输注递增剂量的ONOO(-)(10、20和40微克·千克(-1)·分钟(-1);各45分钟)的反应。肾血流量(RBF)和肾小球滤过率(GFR)通过对氨基马尿酸(PAH)和菊粉清除率来测定。在对照大鼠(n = 6)中,低剂量(10微克·千克(-1)·分钟(-1))的ONOO(-)使RBF增加10±3%,GFR增加15±5%。较高剂量(20和40微克·千克(-1)·分钟(-1))大多使这些反应逆转,RBF分别为-7±4%和-27±7%(P < 0.05),GFR分别为-0.1±4.8%和-14±12%。在输注ONOO(-)期间,尿流量(V)和钠排泄(U(Na)V)没有明显变化。然而,在用一氧化氮合酶(NOS)抑制剂L-硝基精氨酸甲酯(L-NAME,50微克·千克(-1)·分钟(-1);n = 5)预处理的大鼠中,这些剂量的ONOO(-)显著降低了RBF(-26±7%、-27±6%和-44±3%)和GFR(-21±6%、-25±8%和-32±12%),同时V或U(Na)V有不同程度增加。在另一组对照大鼠(n = 5)中,长期输注ONOO(-)(10微克·千克(-1)·分钟(-1),持续75分钟)也显示出类似的血管舒张和超滤过反应。这些数据表明,ONOO(-)在高浓度时作为氧化剂起作用,但在低浓度时提供肾保护功能,这依赖于完整的NOS活性。